title: Follow-up experience with coronary hybrid-revascularisation.
abstract: Minimally invasive direct coronary artery bypass (MIDCAB) grafting is an accepted therapeutical option especially in multimorbid, elderly and reoperative patients with single vessel disease. To expand the benefits of M
authors.affiliation: Department of Cardiothoracic and Vascular Surgery, Friedrich Schiller University, Jena, Germany. Th.Wittwer-MD@t-online.de
authors.forename: T
authors.initials: T
authors.lastname: Wittwer
authors.forename: A
authors.initials: A
authors.lastname: Haverich
authors.forename: J
authors.initials: J
authors.lastname: Cremer
authors.forename: P
authors.initials: P
authors.lastname: Boonstra
authors.forename: U
authors.initials: U
authors.lastname: Franke
authors.forename: T
authors.initials: T
authors.lastname: Wahlers
mesh_terms: D000328:Adult; D000368:Aged; D017023:Coronary Angiography; D003327:Coronary Disease / Q000601:surgery*; D004562:Electrocardiography; D005080:Exercise Test; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D019060:Minimally Invasive Surgical Procedures; D009204:Myocardial Revascularization / Q000379:methods*; D011184:Postoperative Period; D014654:Vascular Patency